Phase I/II Clinical Study of Decitabine Combined With TQB2450 Injection or Decitabine + Anlotinib Combined With TQB2450 Injection in the Treatment of PD-1 Monoclonal Antibody-resistant Digestive System Tumors

Clinical trial NCT04611711 · UNKNOWN

Trial details

NCT number: NCT04611711
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Patients With Digestive System Tumors Resistant to PD-1 Inhibitors

Start date: 2020-11-01
Primary completion: 2020-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.